logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

De novo FL: long-term outcomes with grade 3A disease comparable to those with grades 1-2

No relapses seen after 6 years in patients with grade 3A disease.